Bullboard - Stock Discussion Forum Oncolytics Biotech Inc ONCY

Primary Symbol: T.ONC

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and... see more

Add To Watchlist

TSX:ONC - Post Discussion

Oncolytics Biotech Inc > Endpoints Magazine webinar on OV 08 November 23

View:

Post by askretka on Oct 09, 2023 8:05am

Endpoints Magazine webinar on OV 08 November 23

https://ci5.googleusercontent.com/proxy/DmuFhn3GTX7S-QdEVwV4VoK7-zAoFHlHfAu-cY6MLqK40u2agfroaruLxxVBbtwO9Y-4RoZbbB2MRm5TeJbWugQbtC4rnALNKaiZJD4Jhim-1KyX38WN9Sd6i34ELlMfDCqxXtszAQWcGmSqogoR=s0-d-e1-ft#https://i6.cmail20.com/ei/t/A5/DF1/CB9/220205/csimport/384ac740dea885357cf3c904202ebfdb_5.jpg

Cheers!!!!!!

201

Comment

Comment by Noteable on Oct 09, 2023 9:26am

Also - Re-activating the immune system against cancer: The next I-O revolution https://webinars.endpts.com/

103

Comment

Comment by askretka on Oct 09, 2023 10:07am

It's been quite awhile since Endpoints Magazine has shown OV therapies any love. I'm pretty sure I already known what they are going to say. More coverage is always welcomed though. That Checkpoints and CAR-T have re invigorated interest in OV's as combination therapies. But I'll probably tune in if I have time hopefully. Cheers!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!! ...more

144

Comment

Oncolytics Biotech Inc